5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment

被引:50
|
作者
Yusefi, Mostafa [1 ]
Lee-Kiun, Michiele Soon [2 ]
Shameli, Kamyar [1 ]
Teow, Sin-Yeang [2 ]
Ali, Roshafima Rasit [1 ]
Siew, Kit-Kim [3 ]
Chan, Hui-Yin [2 ]
Wong, Magdelyn Mei-Theng [2 ]
Lim, Wei-Ling [3 ]
Kuca, Kamil [1 ,4 ]
机构
[1] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Jalan Sultan Yahya Petra, Kuala Lumpur 54100, Malaysia
[2] Sunway Univ, Sch Med & Life Sci, Dept Med Sci, Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia
[3] Sunway Univ, Sch Med & Life Sci, Dept Biol Sci, Jalan Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia
[4] Univ Hradec Kralove, Fac Sci, Dept Chem, Hradec Kralove, Czech Republic
关键词
Cellulose; Fe3O4-nanoparticles; Composites; 5-Fluorouracil; Drug carrier system; Colorectal cancer; Microfluidic; Co-culture; TARGETED DRUG-DELIVERY; OXIDE NANOPARTICLES; FIBERS; RICE;
D O I
10.1016/j.carbpol.2021.118523
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Magnetic polymer nanocomposites are inherently multifunctional and harbor assorted physiochemical actions for applications thereof as novel drug nanocarriers. Herein, Fe3O4-nanoparticles were supported on rice straw cellulose for 5-fluorouracil carrier abbreviated as MC/5-FU for potential colorectal cancer treatments. Several analyses indicated the multifunctional properties of MC/5-FU bionanocomposites. Transmission and scanning electron microscopy study demonstrated that Fe3O4 nanofillers covered the cellulose matrix. The drug release from MC/5-FU was evaluated under various pH and temperature conditions, showing the maximum release at pH 7.4 and 44.2 degrees C. In in vitro anticancer assay, MC/5-FU exhibited enhanced selectivity and anticancer actions against 2D monolayer and 3D tumour spheroid models colorectal cancer cells. The anticancer effects of MC/5-FU with magnetic targeting and heat induction were also examined. This easily synthesized MC/5-FU indicated the potential in application as a low-cost drug formulation for colorectal cancer treatments.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL
    MORI, A
    BERTOGLIO, S
    GUGLIELMI, A
    ASCHELE, C
    BOLLI, E
    TIXI, L
    ROSSO, R
    SOBRERO, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 179 - 180
  • [42] 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
    Vodenkova, Sona
    Buchler, Tomas
    Cervena, Klara
    Veskrnova, Veronika
    Vodicka, Pavel
    Vymetalkova, Veronika
    PHARMACOLOGY & THERAPEUTICS, 2020, 206
  • [43] MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil
    Pouya, Fahima Danesh
    Gazouli, Maria
    Rasmi, Yousef
    Lampropoulou, Dimitra Ioanna
    Nemati, Mohadeseh
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (06) : 5165 - 5178
  • [44] Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
    Pan Xie
    Jun-Luan Mo
    Jin-Hong Liu
    Xi Li
    Li-Ming Tan
    Wei Zhang
    Hong-Hao Zhou
    Zhao-Qian Liu
    Cellular Oncology, 2020, 43 : 989 - 1001
  • [45] 5-Fluorouracil induces apoptosis of colorectal cancer cells
    Zhang, J. T.
    Zhou, W. L.
    He, C.
    Liu, T.
    Li, C. Y.
    Wang, L.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (01)
  • [46] Recent Advances in Designing 5-Fluorouracil Delivery Systems: A Stepping Stone in the Safe Treatment of Colorectal Cancer
    Entezar-Almahdi, Elaheh
    Mohammadi-Samani, Soliman
    Tayebi, Lobat
    Farjadian, Fatemeh
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 5445 - 5458
  • [47] Pharmacokinetics-based Dose Management of 5-Fluorouracil Clinical Research in Advanced Colorectal Cancer Treatment
    Deng, Rong
    Shi, Lin
    Zhu, Wei
    Wang, Mei
    Guan, Xin
    Yang, DeLiang
    Shen, Bo
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (02) : 161 - 167
  • [48] Increasing doses of 5-fluorouracil and high-dose folinic acid in the treatment of metastatic colorectal cancer
    Meregalli, M
    Martignoni, G
    Frontini, L
    Zonato, S
    Pavia, G
    Beretta, G
    TUMORI, 1998, 84 (06) : 662 - 665
  • [49] Stimuli-Responsive Liposomes of 5-Fluorouracil: Progressive Steps for Safe and Effective Treatment of Colorectal Cancer
    Alrbyawi, Hamad
    PHARMACEUTICS, 2024, 16 (07)
  • [50] Effect of a 3-hour interval between methotrexate and 5-fluorouracil in the treatment of metastatic colorectal cancer
    Matsumura, Y
    Haruyama, K
    Hamaguchi, T
    Shirao, K
    Muro, K
    Yamada, Y
    Shimada, Y
    Sugano, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (01) : 9 - 13